{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:27:48Z","timestamp":1757618868426,"version":"3.44.0"},"reference-count":58,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Educ Pract Ed"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1136\/adc.2007.127696","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T13:19:29Z","timestamp":1222089569000},"page":"151-158","source":"Crossref","is-referenced-by-count":6,"title":["Drug use in acute meningococcal disease"],"prefix":"10.1136","volume":"93","author":[{"given":"K","family":"Cathie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S N","family":"Faust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2008,9,22]]},"reference":[{"key":"2025090700463493000_93.5.151.1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.5.386"},{"key":"2025090700463493000_93.5.151.2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.5.382"},{"key":"2025090700463493000_93.5.151.3","unstructured":"Paedriatric Intensive Care Audit Network. See www.picanet.org.uk (accessed 5 August 2008)."},{"key":"2025090700463493000_93.5.151.4","unstructured":"Health Protection Agency. Meningococcal disease. Epidemiological data. See http:\/\/www.hpa.org.uk\/webw\/HPAweb&Page&HPAwebAutoListName\/Page\/1201094595391?p\u200a=\u200a1201094595391 (accessed 5 August 2008)."},{"key":"2025090700463493000_93.5.151.5","unstructured":"CDC. Centers for disease control and prevention: morbidity and mortality weekly report (MMWR), 2008. See www.cdc.gov\/mmwr\/PDF\/wk\/mm5553.pdf for 2006 data and www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5652md.htm for 2007 data (both accessed 13 August 2008)."},{"key":"2025090700463493000_93.5.151.6","unstructured":"Health Protection Agency. Invasive meningococcal infections, England and Wales, laboratory reports: weeks 51-52\/2007. Available from http:\/\/www.hpa.org.uk\/hpr\/archives\/2008\/hpr0808.pdf (accessed 5 August 2008)."},{"key":"2025090700463493000_93.5.151.7","unstructured":"Health Protection Agency. Guidance for the public health management of meningococcal disease in the UK, 2006. Available from http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1194947389261 (accessed 5 August 2008)"},{"key":"2025090700463493000_93.5.151.8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.2.195"},{"key":"2025090700463493000_93.5.151.9","doi-asserted-by":"crossref","unstructured":"Matheson NJ Symmonds-Abrahams M Sheikh A . Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2003;(3):CD002744.","DOI":"10.1002\/14651858.CD002744"},{"key":"2025090700463493000_93.5.151.10","unstructured":"NICE. Feverish illness in children - Assessment and initial management in children younger than 5 years London: NICE, 2007 Available from http:\/\/www.nice.org.uk\/cg047 (accessed 5 August 2008)."},{"key":"2025090700463493000_93.5.151.11","unstructured":"FDA. Ceftriaxone (marketed as Rocephin) information. Available from http:\/\/www.fda.gov\/Cder\/drug\/infopage\/ceftriaxone\/default.htm (accessed 5 August 2008)."},{"key":"2025090700463493000_93.5.151.12","unstructured":"Roche. Important clarification of prescribing information. Contraindications. August 2007. http:\/\/www.rocheusa.com\/products\/rocephin\/rocephin-hcp-letter.pdf (accessed 5 August 2008)"},{"issue":"(4)","key":"2025090700463493000_93.5.151.13","first-page":"5","article-title":"Ceftriaxone: incompatibility with calcium-containing solutions.","volume":"1","author":"MHRA","year":"2007","journal-title":"Drug Safety Update"},{"key":"2025090700463493000_93.5.151.14","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.102384"},{"key":"2025090700463493000_93.5.151.15","doi-asserted-by":"crossref","unstructured":"Fraser A Gafter-Gvili A Paul M . Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev 2005;(1):CD004785.","DOI":"10.1002\/14651858.CD004785.pub2"},{"key":"2025090700463493000_93.5.151.16","doi-asserted-by":"crossref","unstructured":"Fraser A Gafter-Gvili A Paul M . Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev 2006;(4):CD004785.","DOI":"10.1002\/14651858.CD004785.pub3"},{"key":"2025090700463493000_93.5.151.17","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.5.449-a"},{"key":"2025090700463493000_93.5.151.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7136.961"},{"key":"2025090700463493000_93.5.151.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040232"},{"issue":"(5)","key":"2025090700463493000_93.5.151.20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/adc.79.5.384","article-title":"Albumin: saint or sinner?","volume":"79","author":"Nadel","year":"1998","journal-title":"Arch Dis Child"},{"key":"2025090700463493000_93.5.151.21","unstructured":"Meningitis Research Foundation. Early management of meningococcal disease in children. Available from http:\/\/www.meningitis.org\/assets\/x\/50150 (accessed 5 August 2008)"},{"key":"2025090700463493000_93.5.151.22","doi-asserted-by":"publisher","DOI":"10.1186\/cc1860"},{"key":"2025090700463493000_93.5.151.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15326-3"},{"key":"2025090700463493000_93.5.151.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7506.1475"},{"key":"2025090700463493000_93.5.151.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.2.e19"},{"key":"2025090700463493000_93.5.151.26","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200206000-00040"},{"issue":"(2)","key":"2025090700463493000_93.5.151.27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/beha.2000.0067","article-title":"Disseminated intravascular coagulation and purpura fulminans secondary to infection.","volume":"13","author":"Faust","year":"2000","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"2025090700463493000_93.5.151.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02712-4"},{"key":"2025090700463493000_93.5.151.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198708273170912"},{"key":"2025090700463493000_93.5.151.30","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709832"},{"key":"2025090700463493000_93.5.151.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441001"},{"key":"2025090700463493000_93.5.151.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60411-5"},{"key":"2025090700463493000_93.5.151.33","unstructured":"FDA. Discontinuation of study F1K-MC-EVBP, Investigation of the efficacy and safety of drotrecogin alfa (activated) in pediatric severe sepsis. 2005. Available from http:\/\/www.fda.gov\/medwatch\/SAFETY\/2005\/xigris_dearHCP_4-21-05.htm (accessed 5 August 2008)."},{"key":"2025090700463493000_93.5.151.34","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000133667.86429.5D"},{"key":"2025090700463493000_93.5.151.35","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000054842.34916.E8"},{"key":"2025090700463493000_93.5.151.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709103171101"},{"key":"2025090700463493000_93.5.151.37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.3.563"},{"key":"2025090700463493000_93.5.151.38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.7.862"},{"key":"2025090700463493000_93.5.151.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071366"},{"key":"2025090700463493000_93.5.151.40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.7.3118"},{"key":"2025090700463493000_93.5.151.41","doi-asserted-by":"publisher","DOI":"10.1086\/515184"},{"key":"2025090700463493000_93.5.151.42","doi-asserted-by":"publisher","DOI":"10.1007\/BF01712247"},{"key":"2025090700463493000_93.5.151.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12106-1"},{"key":"2025090700463493000_93.5.151.44","doi-asserted-by":"publisher","DOI":"10.1136\/adc.83.6.508"},{"key":"2025090700463493000_93.5.151.45","doi-asserted-by":"publisher","DOI":"10.1186\/cc3984"},{"key":"2025090700463493000_93.5.151.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067373"},{"key":"2025090700463493000_93.5.151.47","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000174097.38764.C8"},{"issue":"(2)","key":"2025090700463493000_93.5.151.48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/CMR.6.2.118","article-title":"Pathogenesis and pathophysiology of bacterial meningitis.","volume":"6","author":"Tunkel","year":"1993","journal-title":"Clin Microbiol Rev"},{"issue":"(8996)","key":"2025090700463493000_93.5.151.49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(96)90434-1","article-title":"Activated protein C resistance in childhood stroke.","volume":"347","author":"Ganesan","year":"1996","journal-title":"Lancet"},{"key":"2025090700463493000_93.5.151.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550110063038"},{"key":"2025090700463493000_93.5.151.51","doi-asserted-by":"crossref","unstructured":"van de Beek D de Gans J McIntyre P . Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007;(1):CD004405.","DOI":"10.1002\/14651858.CD004405.pub2"},{"key":"2025090700463493000_93.5.151.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0707474"},{"key":"2025090700463493000_93.5.151.53","doi-asserted-by":"publisher","DOI":"10.1086\/522534"},{"issue":"(9)","key":"2025090700463493000_93.5.151.54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK.","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"issue":"(6)","key":"2025090700463493000_93.5.151.55","first-page":"1477","article-title":"Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity.","volume":"152","author":"Turner","year":"1998","journal-title":"Am J Pathol"},{"key":"2025090700463493000_93.5.151.56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2007.29-c"},{"issue":"(8)","key":"2025090700463493000_93.5.151.57","first-page":"733","article-title":"Serogroup B meningococcal vaccines.","volume":"7","author":"Zimmer","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"2025090700463493000_93.5.151.58","unstructured":"Paediatric Formulary Committee. BNF for children 2007. London: BMJ Publishing Group, RPS Publishing and RCPCH Publications, 2007."}],"container-title":["Archives of disease in childhood - Education & practice edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.2007.127696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:46:46Z","timestamp":1757231206000},"score":1,"resource":{"primary":{"URL":"https:\/\/ep.bmj.com\/lookup\/doi\/10.1136\/adc.2007.127696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,22]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,9,22]]},"published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1136\/adc.2007.127696"],"URL":"https:\/\/doi.org\/10.1136\/adc.2007.127696","relation":{},"ISSN":["1743-0585","1743-0593"],"issn-type":[{"type":"print","value":"1743-0585"},{"type":"electronic","value":"1743-0593"}],"subject":[],"published":{"date-parts":[[2008,9,22]]}}}